NewcelX NCEL
NASDAQ NCEL
$2.79 +0.03 (+1.05%)
As of: Oct 21, 2026 · 3:59 PM EDT

NewcelX (NCEL) Retained Earnings (2019 - 2026)

Updated

NewcelX (NCEL) reported Retained Earnings of -$90.48 million for Q2 2026, compared with -$87.73 million a year earlier.

Analysis

NewcelX (NCEL) Retained Earnings (2019 - 2026) Analysis & Trends

At the end of FY2025, NewcelX posted Retained Earnings of -$84.89 million.

  • By year, Retained Earnings came in at -$76.59 million in FY2024, -$69.35 million in FY2023, -$66.08 million in FY2022 and -$41.71 million in FY2021.
  • The Q2 2026 figure ranks as the lowest quarterly Retained Earnings in data going back to Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 31.89 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 171.67 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -17.33 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 63.27 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 12.59 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -22.28 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 2.20 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 112.09 Bn
10 NewcelX 11.34 Mn 4.68 Mn - -90.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -90.48 Mn
Dec 31, 2025 -84.89 Mn
Jun 30, 2025 -74.81 Mn
Dec 31, 2024 -76.59 Mn
Jun 30, 2024 -72.41 Mn
Dec 31, 2023 -70.37 Mn
Jun 30, 2023 -65.81 Mn
Dec 31, 2022 -58.20 Mn
Jun 30, 2022 -50.35 Mn
Dec 31, 2021 -41.71 Mn
Jun 30, 2021 -34.36 Mn
Dec 31, 2020 -29.76 Mn
Dec 31, 2019 -26.90 Mn
API Access

NewcelX Retained Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=retained-earnings&ticker=NCEL&period=max&api_key=YOUR_API_KEY